Following an extensive international search, Emory University announced today that Ravi I. Thadhani, MD, MPH, has been appointed executive vice president for health affairs (EVPHA). Thadhani also will serve as executive director of Emory’s Woodruff Health Sciences Center and vice chair of the Emory Healthcare Board of Directors. He will begin his tenure at Emory on Jan. 1, 2023.
“Dr. Thadhani is a dynamic and innovative leader for Emory’s Woodruff Health Sciences Center,” says Emory President Gregory L. Fenves. “He has deep experience in delivering the highest-quality health care, advancing biomedical research, training health professionals and serving the public to improve the health of all. He will inspire Emory’s talented doctors, nurses, frontline staff, faculty and researchers to reach new heights of excellence. In his many years of academic health system leadership, he has never stopped his research and clinical work, which is a testament to his lifelong commitment to serving patients and improving community health. I can’t wait for him to get started at Emory.”
Thadhani currently serves as chief academic officer and dean for faculty affairs for Mass General Brigham and professor of medicine at Harvard Medical School, both in Boston, Massachusetts. At Mass General Brigham, he is a member of the executive leadership team and oversees graduate medical education, professional development and a $2.3 billion research enterprise. Previously, he served as vice dean of research and graduate research education at Cedars-Sinai Medical Center in Los Angeles (2017-2019), associate director of research at Mass General Brigham (2012-2017) and chief of nephrology at Massachusetts General Hospital (2013-2017).
“I am excited to be coming to Emory University and honored to be joining its outstanding leadership team,” says Thadhani. “Emory’s commitment to serving the Georgia community is impressive and is the driver for its international reputation as a leader in health care delivery and health sciences research, discovery and innovation.”
As EVPHA, Thadhani will oversee Emory’s academic health sciences center, the Woodruff Health Sciences Center (WHSC), and in this position will shape the next era of research, training and health-care delivery innovation. Founded in 1966, WHSC includes Emory’s schools of medicine, public health and nursing; Winship Cancer Institute; Emory National Primate Research Center; Emory Global Health Institute; Goizueta Institute @ Emory Brain Health; Emory Global Diabetes Research Center; and Emory Healthcare.
Emory Healthcare, with more than 24,000 employees, 11 hospital campuses and 425 locations, is the most comprehensive academic health system in Georgia. As EVPHA and vice chair of the Emory Healthcare Board, Thadhani will provide oversight of Emory Healthcare’s CEO and leadership team, ensuring the delivery of high-quality, patient-centered care focused on supporting the health and well-being of patients around the state.
“As a physician leader and researcher, Dr. Thadhani understands the needs of patients and how those needs translate to the mission of the Woodruff Health Sciences Center, including Emory Healthcare,” says John Rice, chair of the WHSC Committee of Emory’s Board of Trustees and chair of the Emory Healthcare Board of Directors. “He has a vision for the future that will support our community to address complex health care needs not only in Atlanta and Georgia but around the world.”
With more than 30 years as a general and specialized internal medicine physician, Thadhani has extensive experience in patient care, research and clinical trials. He has led a successful research lab with continuous federal funding for more than 25 years, with a focus on kidney disease and developing diagnostics and therapeutics for patients with preeclampsia. Thadhani has performed several clinical trials focused on effective treatments and preventative measures for preeclampsia, which is one of the leading causes of maternal and perinatal morbidity and mortality.
He is the author or co-author of more than 300 scientific manuscripts and has published in top-tier journals including the New England Journal of Medicine, Lancet and Journal of the American Medical Association. Thadhani has been inducted into several honor societies, including the American Society for Clinical Investigation, Association of American Physicians, American Epidemiological Society and the American Clinical and Climatological Association. He also serves as a board member of the Broad Institute of MIT and Harvard, a research organization that convenes a community of researchers from across many disciplines and partner institutions — MIT, Harvard and Harvard-affiliated hospitals.
A recipient of several distinguished national awards, Thadhani has an extensive track record of recruiting and mentoring women and underrepresented staff, trainees and faculty. He has been honored with the Harold Amos Faculty Diversity Award from Harvard Medical School, the Alumni Award of Merit from the Harvard T.H. Chan School of Public Health and the John P. Peters Award from the American Society of Nephrology.
Thadhani earned his doctor of medicine degree from the University of Pennsylvania School of Medicine in 1991. He received a master of public health degree from the Harvard T.H. Chan School of Public Health and a bachelor’s degree from the University of Notre Dame. He also completed the LEAD Innovation Certificate Program in 2020 at the Stanford University Graduate School of Business.
“This is an exciting time at Emory, and I look forward to supporting the tripartite mission of education, research and clinical care of the Woodruff Health Sciences Center and advancing its commitment to diversity, equity, inclusion and justice,” says Thadhani. “There is no limit to what we can accomplish with the remarkable faculty, staff and students at Emory.”
About Emory University School of Medicine:
“We are living at a unique time in biomedical history. We’ve seen a revolution in complementary forces that are helping us change the way we think of medicine.
For the first time, we have a complete “parts list” of genes and other building blocks, which means we can personalize therapies. At the same time, we have an IT revolution that lets us gather data, mine it and visualize it in sophisticated ways, and act on it in real time in the ICU or predict problems with anticipatory medicine. And new technology allows us to probe the human organism through imaging and other areas, to visualize what’s going on. Add to those the twenty-first century patients, who are well-informed, empowered, and incredible advocates for change.
These forces are converging to allow us to take on the big problems, and have a good chance of finding solutions to ones that have frustrated us for so long.
Embedded within Emory University, we have links to the business school, the department of chemistry, and many other academic resources that are traditionally outside the realm of health care. We have hospitals where we teach the next generation of health professionals to provide the most advanced, compassionate patient care. We have research institutes and government and industry partnerships racing to find the next discovery or cure.
We have all of this in one location, with a structure that allows those important interdisciplinary interactions to occur. With these resources and our team of bold thinkers who are willing to take risks in order to achieve something great, we believe there are no limits to what we can accomplish.
The Emory University School of Medicine is a leading institution with the highest standards in education, biomedical research, and patient care.
We are committed to recruiting and developing a diverse group of students and innovative leaders in biomedical science, public health, medical education, and clinical care.
We foster a culture that integrates leading edge basic, translational, and clinical research to further the ability to deliver quality health care, to predict illness and treat the sick, and to promote health of our patients and community.”
About Ravi I. Thadhani, MD, MPH:
“Ravi I. Thadhani, MD, MPH, was appointed Chief Academic Officer at Mass General Brigham in November 2019. He is a Professor of Medicine and Academic Dean at Harvard Medical School. Previously, he served as Vice Dean of Research and Graduate Research Education at Cedars-Sinai Medical Center in Los Angeles (2017-2019), Associate Director of Research at Mass General Brigham (2012-2017) and Chief of Nephrology at Massachusetts General Hospital (2013-2017).
In his role as Chief Academic Officer, Dr. Thadhani oversees a ~$1.8B research enterprise, graduate medical education and continuing professional development for Mass General Brigham. Dr. Thadhani is a member of the Mass General Brigham executive leadership team under the direction of Anne Klibanski, MD, President and Chief Executive Officer. Dr. Thadhani works with senior leadership across the Mass General Brigham system on a number of system strategic initiatives.
Dr. Thadhani also managed a successful research laboratory for approximately 25 years with continuous federal funding and employing data managers, operations directors, statisticians, nurses, research assistants and laboratorians. He has published more than 300 manuscripts, including in the top medical and nephrology journals—New England Journal of Medicine, Journal of the American Medical Association, and Journal of the American Society of Nephrology. Dr. Thadhani has been inducted to several honor societies, including the American Society for Clinical Investigation, Association of American Physicians, American Epidemiological Society and the American Clinical and Climatological Association. He has also received several distinguished national awards, including the Harold Amos Faculty Diversity Award from Harvard Medical School—the highest award for fostering diversity at Harvard Medical School; Alumni Award from the Harvard School of Public Health—a significant achievement and the John P. Peters Award from the American Society of Nephrology—for mentorship and scientific achievements.”